Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 63

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 63
---
5.

(18)One-third of these unvested restricted stock units are subject to vesting on each of March 15, 2025, 2026 and 2027.

(19)These options vest upon the later of (i) the date on which the average closing price of the Company’s stock over a consecutive thirty (30) calendar day period has been equal to or greater than 150% of the option price and (ii) the date or dates on which the applicable service-based conditions are met. The service conditions are met one-third on June 10, 2025, and the remaining two-thirds are subject to vesting in substantially equal quarterly installments thereafter.

(20)These unvested options are subject to vesting on June 10, 2027.

(21)One-third of these unvested restricted stock units are subject to vesting on each of June 10, 2025, 2026 and 2027.

<div align='center'>52</div>

(22)These options vest upon the later of (i) the date on which the average closing price of the Company’s stock over a consecutive thirty (30) calendar day period has been equal to or greater than 150% of the option price and (ii) the date or dates on which the applicable service-based conditions are met. The service conditions are met one-third on March 15, 2025, and the remaining two-thirds are subject to vesting in substantially equal quarterly installments thereafter.

(23)One-third of these unvested restricted stock units are subject to vesting on each of March 15, 2025, 2026 and 2027.

(24)These unvested restricted stock units are subject to vesting on March 15, 2027.

For a summary of our standard option agreements, see “Compensation Discussion and Analysis – Elements of Executive Compensation – Long-Term Equity-Based Incentives.”

<div align='center'>53</div>

| OPTION EXERCISES AND STOCK VESTED |

The following table provides information about the number of shares issued (i) upon option exercises, and the value realized upon exercise, or (ii) upon the vesting of restricted stock/restricted stock units, and the value realized upon vesting, by our named executive officers during fiscal 2024.

| Name                                     
 Active Officers as of December 31, 2024: | Option Awards 
 Number        
 of Shares     
 Acquired on